|
|
FDADocs 5/9/2008 | 0 (0) | 84 | 1 | 0 | English
sNDA 20-726 FDA MEDICAL AND STATISTICAL ODAC REPORTDrug Name: Femara?? Letrozole tablets Applicant: Novartis Date Submitted: July 11, 2000 Date Received: July 12, 2000 Date of Review: November ... more>>
FDADocs 5/9/2008 | 0 (0) | 47 | 1 | 0 | English
FDA DRUG AND DEVICE PRODUCT APPROVALSVolume 17 (1) January 1994Center for Drug Evaluation and Research *George R. Scott (301) 443-3910 Center for Biologics Evaluation and Research Joseph ... more>>
FDADocs 5/12/2008 | 0 (0) | 21 | 1 | 0 | English
The Division of Drug Marketing, Advertising, and Communications (DDMAC) protects the public health by assuring prescription drug information is truthful, balanced, and accurately c... ... more>>
FDADocs 5/9/2008 | 0 (0) | 16 | 1 | 0 | English
CDER Forum for International Drug Regulatory AuthoritiesApril 16 ??? 20, 2007CDER???s International ProgramJustina A. Molzon, M.S. Pharm., J.D. Associate Director for Inter... ... more>>
FDADocs 5/5/2008 | 0 (0) | 19 | 1 | 0 | English
Embryonic Stem Cell-based Therapies: US-FDA Regulatory ExpectationsDonald W. Fink, Jr., Ph.D.Phone: (301) 827-5153 E-Mail: donald.fink@fda.hhs.govOffice of Cellular, Tissue and Gene Therapies ... more>>
FDADocs 5/9/2008 | 0 (0) | 30 | 1 | 0 | English
13 years. Materials and Methods: The FDA granted marketing approval to 71 oncology drug applications...End Points and United States Food and Drug Administration Approval of Oncology DrugsBy John R ... more>>
FDADocs 5/12/2008 | 0 (0) | 36 | 1 | 0 | English
Hospital Acquired Pneumonia (HAP) Joint FDA/IDSA/PhRMA WorkshopSary Beidas, MD Medical Officer CDER/DSPIDPNovember 20, 2002Definition of HAP (& Diagnosis):???Clinical: Temp, WBC, Sputum ... more>>
FDADocs 5/9/2008 | 0 (0) | 25 | 1 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 35 | 1 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 26 | 1 | 0 | English
SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he... ... more>>
FDADocs 5/5/2008 | 0 (0) | 32 | 1 | 0 | English
SUMMARY BASIS FOR APPROVALReference Numbers: Biological Product Name: Manufacturer: 87-0508 and 87-0509 Fibrin Sealant 6sterreichisches Institut Fiir Haemoderivate Subsidiary of IMMUNO AG (QIH ... more>>
FDADocs 5/9/2008 | 0 (0) | 57 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 59 | 0 | 0 | English
NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 68 | 0 | 0 | English
Guidance for Industry and FDA Staff FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance AssessmentDocument Issued on: October 8, 2003For ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 156 | 0 | 0 | English
Guidance for Industry and FDA Staff Premarket Approval Application Modular ReviewDocument issued... Wolanski (CDRH) at 301-594-2186 or by e- mail at nlw@cdrh.fda.gov. For questions rega rding the ... more>>
| | | |
| results / page 15/25/50 |
Page: 4 of 33
|
4...
|
|